Navigation Links
Nektar Therapeutics' President and CEO Howard W. Robin to Present at the Jefferies 2011 Global Healthcare Conference in New York
Date:6/1/2011

SAN FRANCISCO, June 1, 2011 /PRNewswire/ -- Nektar Therapeutics' (Nasdaq: NKTR) President and Chief Executive Officer, Howard W. Robin, is scheduled to present at the Jefferies 2011 Global Healthcare Conference at The Grand Hyatt New York on Tuesday, June 7, 2011 at 10:00 a.m. Eastern Time.

The presentation will be accessible via a Webcast through a link posted on the Investor Relations, Events Calendar section of the Nektar website http://www.nektar.com. This webcast will be available for replay until July 7, 2011.

About NektarNektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms. Nektar has a robust R&D pipeline of potentially high-value therapeutics in oncology, pain and other areas. In the area of pain, Nektar has an exclusive worldwide license agreement with AstraZeneca for NKTR-118, an investigational drug candidate, being evaluated in Phase 3 clinical studies as a once-daily, oral tablet for the treatment of opioid-induced constipation.  The agreement also includes NKTR-119, an earlier stage development program that is a co-formulation of NKTR-118 and an opioid.  NKTR-181, a novel mu-opioid analgesic molecule, is being evaluated in Phase 1 clinical studies.  In oncology, NKTR-102, a novel topoisomerase I-inhibitor, is being evaluated in Phase 2 clinical studies for the treatment of breast, ovarian and colorectal cancers.  NKTR-105, a novel anti-mitotic agent, is in a Phase 1 clinical study in cancer patients with refractory solid tumors.

Nektar's technology has enabled seven approved products in the U.S. or Europe through partnerships with leading biopharmaceutical companies, including UCB's Cimzia® for Crohn's disease and rheumatoid arthritis, Roche's PEGASYS® for hepatitis C
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Nektar Announces New Phase 2 Data for NKTR-102 to Be Presented at 2011 ASCO Annual Meeting
2. FDA Grants Orphan Drug Designation for Nektars Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer
3. Nektar to Announce Financial Results for the First Quarter of 2011 on Wednesday, April 27, 2011, After Close of U.S.-Based Financial Markets
4. Nektar Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results
5. Nektar Therapeutics President and CEO Howard W. Robin to Present at the 31st Annual Cowen and Company Healthcare Conference in Boston
6. Nektar to Announce Financial Results for the Fourth Quarter and Year-End of 2010 on Tuesday, March 1, 2011, After Close of U.S.-Based Financial Markets
7. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco, CA
8. Nektar Therapeutics Reports Third Quarter 2010 Financial Results
9. Nektar to Announce Financial Results for the Third Quarter of 2010 on Thursday, November 4, 2010, After Close of U.S.-Based Financial Markets
10. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
11. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Pepperl+Fuchs, a world leader in process ... leading provider of HART protocol devices. The move ... its integrated solutions offerings and strengthen its position ... are pleased to add the MACTek WirelessHART product ... Bolin , Pepperl+Fuchs, executive vice president of the ...
(Date:8/31/2015)... Aug. 31, 2015  Ascendant Solutions, Inc. (Pink Sheets: ... that its Healthcare subsidiary, Dougherty,s Holdings, has acquired Springtown ... downtown square of Springtown, Texas , ... years, this community-based pharmacy has provided retail prescriptions, healthcare ... Springtown . The ...
(Date:8/31/2015)... 2015  Daktari Diagnostics today announced a collaboration with Merck, ... and Canada , to develop Daktari,s ... up to $8.5 million over the next 3.5 years, will ... regulatory approval of Daktari,s HCV test. The ... can detect low levels of virus directly in a single ...
Breaking Medicine Technology:Ascendant Solutions, Inc. Announces Completion of Fifth Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary 2Ascendant Solutions, Inc. Announces Completion of Fifth Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary 3Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 2Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 3
(Date:9/1/2015)... NY (PRWEB) , ... September 01, 2015 , ... ... to date, more than 1,500 investor-families have received permanent green cards (I-829 petition ... projects. , The I-829 petition is the final step of the EB-5 visa ...
(Date:9/1/2015)... ... 01, 2015 , ... Situations requiring fast, easy-to-understand business and ... convenient time for everyone involved. These occasions highlight the value of a professional ... has real people available to handle any translation assignment at any time ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... MAP Recovery Network, the Premier Outcomes-Driven Provider Network. It is the first-ever, ... dedicated to the provision of quality addiction treatment and the utilization of ...
(Date:9/1/2015)... ... 01, 2015 , ... Elizabeth Callahan, MD, founder and medical director of ... to offer RADIESSE® filler treatment for volume loss in the hands. RADIESSE provides an ... in the hands, delivering smooth, natural-looking results that can last up to one year ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... sponsored an educational workshop for physician assistants (PAs) practicing in orthopedics. The workshop, ... Zeel™” was held by Dr. Erick Salado, an orthopedic surgeon at South Florida ...
Breaking Medicine News(10 mins):Health News:CanAm Enterprises Reaches Another Milestone with More Than 1,500 I-829 Petition Approvals 2Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 2Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 3Health News:MAP Health Management Launches the MAP Recovery Network 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 3Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 2Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 3
... The College of Optometrists in Vision,Development (COVD) ... O.D., FCOVD, was installed as its 29th president ... Meeting held on,October 20. Dr. Fortenbacher, 53, who ... for eight years, assumes the new role and ...
... Nov. 2 Addressing more than,100 cardiologists and ... chairman and CEO, set out four critical priorities ... today at,Schering-Plough,s fourth annual Cardiovascular Summit in advance ... In his speech, Hassan emphasized the potential ...
... 2 This week in Washington,experts and activists on ... Yoweri Museveni, acting on concerns raised by a number ... the US,to give a speech on AIDS policy, sponsored ... President Bush., "Ugandans deserve respect and recognition for ...
... But most humans couldn,t maintain such a low-cal diet, ... Cutting back drastically on daily calorie intake can lead ... at Buffalo researchers. , They speculate that this kind ... age, slowing the progression to disability. , A lifelong ...
... 2 Shoot For a Cure, the 15th anniversary,celebration ... Hospital, will be held at 6 p.m. Thursday, Nov. ... This year,s celebration will honor Bloomfield resident Penny B.,Blumenstein, ... System. The evening will include an auction, dinner ...
... Nov. 2 ABR-Affinity,BioReagents, a leading global antibody manufacturer, ... Society for,Neuroscience Meeting in San Diego, California, November 3 ... past week and a half, the influx of meeting,participants ... hard hit,economy of the region. "All of the staff ...
Cached Medicine News:Health News:Dr. Dan L. Fortenbacher, O.D., FCOVD, Becomes 29th President of 'College of Optometrists in Vision Development' (COVD); Unveils 7-Part Development Plan for Ongoing Growth 2Health News:Dr. Dan L. Fortenbacher, O.D., FCOVD, Becomes 29th President of 'College of Optometrists in Vision Development' (COVD); Unveils 7-Part Development Plan for Ongoing Growth 3Health News:Schering-Plough CEO Calls for Four-Pronged Approach to Improving Current Health Care Environment 2Health News:President Museveni's Visit Protested by HIV/AIDS Experts 2Health News:Calorie-Starved Rats Live Longer: Study 2Health News:ABR-Affinity BioReagents Announces Its Continued Support for the Society for Neuroscience Annual Meeting in San Diego, November 3 - 7, 2007 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: